<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Beta Footprint &#187; study</title>
	<atom:link href="http://www.betafootprint.com/tag/study/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.betafootprint.com</link>
	<description>Carbon footprint reduction guide</description>
	<lastBuildDate>Fri, 11 Dec 2009 10:20:44 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Asymmetric endoscopic inflammation of the ileal pouch: A sign of ischemic pouchitis?</title>
		<link>http://www.betafootprint.com/medical-news/asymmetric-endoscopic-inflammation-of-the-ileal-pouch-a-sign-of-ischemic-pouchitis/</link>
		<comments>http://www.betafootprint.com/medical-news/asymmetric-endoscopic-inflammation-of-the-ileal-pouch-a-sign-of-ischemic-pouchitis/#comments</comments>
		<pubDate>Fri, 11 Dec 2009 10:20:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[groups]]></category>
		<category><![CDATA[inflamm-bowel]]></category>
		<category><![CDATA[may-represent]]></category>
		<category><![CDATA[pouch]]></category>
		<category><![CDATA[pouchitis-did]]></category>
		<category><![CDATA[pouchitis-were]]></category>
		<category><![CDATA[staple-suture]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-pouch]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/asymmetric-endoscopic-inflammation-of-the-ileal-pouch-a-sign-of-ischemic-pouchitis/</guid>
		<description><![CDATA[ Inflamm Bowel Dis . 2009 Dec 8; Shen B, Plesec TP, Remer E, Kiran P, Remzi FH, Lopez R, Fazio VW, Goldblum JR BACKGROUND:: Pouchitis is associated with dysbiosis and dysregulated mucosal immunity, although secondary pouchitis with special etiologic factors, such as ischemia, can occur. The aim was to describe a disease phenotype of the ileal pouch with an endoscopic appearance suggestive of ischemia]]></description>
			<content:encoded><![CDATA[<p> Inflamm Bowel Dis . 2009 Dec 8; Shen B, Plesec TP, Remer E, Kiran P, Remzi FH, Lopez R, Fazio VW, Goldblum JR BACKGROUND:: Pouchitis is associated with dysbiosis and dysregulated mucosal immunity, although secondary pouchitis with special etiologic factors, such as ischemia, can occur. The aim was to describe a disease phenotype of the ileal pouch with an endoscopic appearance suggestive of ischemia</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/asymmetric-endoscopic-inflammation-of-the-ileal-pouch-a-sign-of-ischemic-pouchitis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation.</title>
		<link>http://www.betafootprint.com/medical-news/sulforaphane-protects-immature-hippocampal-neurons-against-death-caused-by-exposure-to-hemin-or-to-oxygen-and-glucose-deprivation/</link>
		<comments>http://www.betafootprint.com/medical-news/sulforaphane-protects-immature-hippocampal-neurons-against-death-caused-by-exposure-to-hemin-or-to-oxygen-and-glucose-deprivation/#comments</comments>
		<pubDate>Fri, 11 Dec 2009 10:20:39 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[after-the-ogd]]></category>
		<category><![CDATA[against-injury]]></category>
		<category><![CDATA[control-neurons]]></category>
		<category><![CDATA[hypothesis]]></category>
		<category><![CDATA[nrf2-dependent]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-antioxidant]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/sulforaphane-protects-immature-hippocampal-neurons-against-death-caused-by-exposure-to-hemin-or-to-oxygen-and-glucose-deprivation/</guid>
		<description><![CDATA[ J Neurosci Res . 2009 Dec 8; Soane L, Li Dai W, Fiskum G, Bambrick LL Oxidative stress is a mediator of cell death following cerebral ischemia/reperfusion and heme toxicity, which can be an important pathogenic factor in acute brain injury. ]]></description>
			<content:encoded><![CDATA[<p> J Neurosci Res . 2009 Dec 8; Soane L, Li Dai W, Fiskum G, Bambrick LL Oxidative stress is a mediator of cell death following cerebral ischemia/reperfusion and heme toxicity, which can be an important pathogenic factor in acute brain injury. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/sulforaphane-protects-immature-hippocampal-neurons-against-death-caused-by-exposure-to-hemin-or-to-oxygen-and-glucose-deprivation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tripep Receives Approval For Expanding The ChronVac-C(R) Study With One More Vaccination</title>
		<link>http://www.betafootprint.com/uncategorized/tripep-receives-approval-for-expanding-the-chronvac-cr-study-with-one-more-vaccination/</link>
		<comments>http://www.betafootprint.com/uncategorized/tripep-receives-approval-for-expanding-the-chronvac-cr-study-with-one-more-vaccination/#comments</comments>
		<pubDate>Fri, 11 Dec 2009 05:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[approval]]></category>
		<category><![CDATA[chron]]></category>
		<category><![CDATA[given-at-three]]></category>
		<category><![CDATA[highest]]></category>
		<category><![CDATA[highest-dose]]></category>
		<category><![CDATA[immune system / vaccines]]></category>
		<category><![CDATA[products-agency]]></category>
		<category><![CDATA[received-four]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[therapeutic]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/tripep-receives-approval-for-expanding-the-chronvac-cr-study-with-one-more-vaccination/</guid>
		<description><![CDATA[Tripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one additional treatment with the therapeutic vaccine. All twelve patients in the study have earlier received four treatments with ChronVac-C® given at three different doses and one month apart]]></description>
			<content:encoded><![CDATA[<p>Tripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one additional treatment with the therapeutic vaccine. All twelve patients in the study have earlier received four treatments with ChronVac-C® given at three different doses and one month apart</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/tripep-receives-approval-for-expanding-the-chronvac-cr-study-with-one-more-vaccination/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cedars-Sinai Regenerative Medicine Institute To Supply Stem Cells To Scientists Developing Treatments For Huntington&#8217;s Disease</title>
		<link>http://www.betafootprint.com/uncategorized/cedars-sinai-regenerative-medicine-institute-to-supply-stem-cells-to-scientists-developing-treatments-for-huntingtons-disease/</link>
		<comments>http://www.betafootprint.com/uncategorized/cedars-sinai-regenerative-medicine-institute-to-supply-stem-cells-to-scientists-developing-treatments-for-huntingtons-disease/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 14:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[adult]]></category>
		<category><![CDATA[cedars]]></category>
		<category><![CDATA[huntingtons disease]]></category>
		<category><![CDATA[institute]]></category>
		<category><![CDATA[medicine-institute]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[provide-stem]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/cedars-sinai-regenerative-medicine-institute-to-supply-stem-cells-to-scientists-developing-treatments-for-huntingtons-disease/</guid>
		<description><![CDATA[The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington's disease. ]]></description>
			<content:encoded><![CDATA[<p>The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington&#8217;s disease. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/cedars-sinai-regenerative-medicine-institute-to-supply-stem-cells-to-scientists-developing-treatments-for-huntingtons-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Not All Parents Place Their Babies &#8216;Back To Sleep,&#8217; Yale Research Finds</title>
		<link>http://www.betafootprint.com/uncategorized/not-all-parents-place-their-babies-back-to-sleep-yale-research-finds/</link>
		<comments>http://www.betafootprint.com/uncategorized/not-all-parents-place-their-babies-back-to-sleep-yale-research-finds/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 14:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[child]]></category>
		<category><![CDATA[guidelines-were]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[pediatrics]]></category>
		<category><![CDATA[reduce-the-risk]]></category>
		<category><![CDATA[school]]></category>
		<category><![CDATA[sleep-position]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[sudden-infant]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/not-all-parents-place-their-babies-back-to-sleep-yale-research-finds/</guid>
		<description><![CDATA[Placing infants on their backs for sleep can help reduce the risk of Sudden Infant Death Syndrome (SIDS). But a study by Yale School of Medicine researchers and their colleagues shows that while the practice helped reduce the incidence of SIDS, it has reached a plateau since guidelines were released by the National Institute of Child Health and Human Development. Published in the December issue of the Archives of Pediatrics and Adolescent Medicine, the study is based on data from the National Infant Sleep Position Study, an annual telephone survey of about 1,000 households with infants... ]]></description>
			<content:encoded><![CDATA[<p>Placing infants on their backs for sleep can help reduce the risk of Sudden Infant Death Syndrome (SIDS). But a study by Yale School of Medicine researchers and their colleagues shows that while the practice helped reduce the incidence of SIDS, it has reached a plateau since guidelines were released by the National Institute of Child Health and Human Development. Published in the December issue of the Archives of Pediatrics and Adolescent Medicine, the study is based on data from the National Infant Sleep Position Study, an annual telephone survey of about 1,000 households with infants&#8230; </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/not-all-parents-place-their-babies-back-to-sleep-yale-research-finds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Severity Of H1N1 Flu In US During Current Flu Season May Be Less Than Feared</title>
		<link>http://www.betafootprint.com/uncategorized/severity-of-h1n1-flu-in-us-during-current-flu-season-may-be-less-than-feared/</link>
		<comments>http://www.betafootprint.com/uncategorized/severity-of-h1n1-flu-in-us-during-current-flu-season-may-be-less-than-feared/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 14:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[harvard]]></category>
		<category><![CDATA[harvard-school]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[most-accurate]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[study-appears]]></category>
		<category><![CDATA[swine-flu]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/severity-of-h1n1-flu-in-us-during-current-flu-season-may-be-less-than-feared/</guid>
		<description><![CDATA[A new study from researchers at the UK Medical Research Council and the Harvard School of Public Health (HSPH) projects that the severity of the H1N1 flu during the autumn-winter flu season in the U.S. will likely be less than previously feared. ]]></description>
			<content:encoded><![CDATA[<p>A new study from researchers at the UK Medical Research Council and the Harvard School of Public Health (HSPH) projects that the severity of the H1N1 flu during the autumn-winter flu season in the U.S. will likely be less than previously feared. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/severity-of-h1n1-flu-in-us-during-current-flu-season-may-be-less-than-feared/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Childhood Traumas Linger As Health Risk Factors For Adults</title>
		<link>http://www.betafootprint.com/uncategorized/childhood-traumas-linger-as-health-risk-factors-for-adults/</link>
		<comments>http://www.betafootprint.com/uncategorized/childhood-traumas-linger-as-health-risk-factors-for-adults/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 13:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[childhood-abuse]]></category>
		<category><![CDATA[childhood-may]]></category>
		<category><![CDATA[college-london]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[dunedin]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[health-risks]]></category>
		<category><![CDATA[latest]]></category>
		<category><![CDATA[latest-research]]></category>
		<category><![CDATA[psychiatry]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/childhood-traumas-linger-as-health-risk-factors-for-adults/</guid>
		<description><![CDATA[Research from the Institute of Psychiatry at King's College London has found that negative experiences in childhood may alter not only mental health but also physical health, into middle age and beyond. ]]></description>
			<content:encoded><![CDATA[<p>Research from the Institute of Psychiatry at King&#8217;s College London has found that negative experiences in childhood may alter not only mental health but also physical health, into middle age and beyond. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/childhood-traumas-linger-as-health-risk-factors-for-adults/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Type 2 Diabetes Gene Predisposes Children To Obesity</title>
		<link>http://www.betafootprint.com/uncategorized/type-2-diabetes-gene-predisposes-children-to-obesity/</link>
		<comments>http://www.betafootprint.com/uncategorized/type-2-diabetes-gene-predisposes-children-to-obesity/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 12:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[finding-sheds]]></category>
		<category><![CDATA[genetic]]></category>
		<category><![CDATA[journal]]></category>
		<category><![CDATA[online]]></category>
		<category><![CDATA[pennsylvania]]></category>
		<category><![CDATA[raises-the-risk]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[university]]></category>
		<category><![CDATA[upswing]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/type-2-diabetes-gene-predisposes-children-to-obesity/</guid>
		<description><![CDATA[Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which has been on the upswing in childhood and adolescence]]></description>
			<content:encoded><![CDATA[<p>Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which has been on the upswing in childhood and adolescence</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/type-2-diabetes-gene-predisposes-children-to-obesity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acute digital ischemia: A neglected microsurgical emergency. Report of 17 patients and literature review.</title>
		<link>http://www.betafootprint.com/medical-news/acute-digital-ischemia-a-neglected-microsurgical-emergency-report-of-17-patients-and-literature-review/</link>
		<comments>http://www.betafootprint.com/medical-news/acute-digital-ischemia-a-neglected-microsurgical-emergency-report-of-17-patients-and-literature-review/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 09:34:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[acute-digital]]></category>
		<category><![CDATA[aneurysm]]></category>
		<category><![CDATA[degrees-flexion]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[literature]]></category>
		<category><![CDATA[mean-follow-up]]></category>
		<category><![CDATA[microsurgery]]></category>
		<category><![CDATA[performed-each]]></category>
		<category><![CDATA[reconstruction]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-literature]]></category>
		<category><![CDATA[thoracic-outlet]]></category>
		<category><![CDATA[upto-the-palmar]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/acute-digital-ischemia-a-neglected-microsurgical-emergency-report-of-17-patients-and-literature-review/</guid>
		<description><![CDATA[ Microsurgery . 2009 Dec 4; Leclère FM, Mordon S, Schoofs M This study was performed to review our 16-year experience in acute finger ischemia. A review of the literature was also performed. ]]></description>
			<content:encoded><![CDATA[<p> Microsurgery . 2009 Dec 4; Leclère FM, Mordon S, Schoofs M This study was performed to review our 16-year experience in acute finger ischemia. A review of the literature was also performed. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/acute-digital-ischemia-a-neglected-microsurgical-emergency-report-of-17-patients-and-literature-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Application of fetal neural stem cells transplantation in delaying denervated muscle atrophy in rats with peripheral nerve injury.</title>
		<link>http://www.betafootprint.com/medical-news/application-of-fetal-neural-stem-cells-transplantation-in-delaying-denervated-muscle-atrophy-in-rats-with-peripheral-nerve-injury/</link>
		<comments>http://www.betafootprint.com/medical-news/application-of-fetal-neural-stem-cells-transplantation-in-delaying-denervated-muscle-atrophy-in-rats-with-peripheral-nerve-injury/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 09:34:25 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[after-the-nerve]]></category>
		<category><![CDATA[denervated]]></category>
		<category><![CDATA[group-comparing]]></category>
		<category><![CDATA[mechanism]]></category>
		<category><![CDATA[muscle-atrophy]]></category>
		<category><![CDATA[pathway-between]]></category>
		<category><![CDATA[skeletal-muscle]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-denervated]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/application-of-fetal-neural-stem-cells-transplantation-in-delaying-denervated-muscle-atrophy-in-rats-with-peripheral-nerve-injury/</guid>
		<description><![CDATA[ Microsurgery . 2009 Dec 4; Gu S, Shen Y, Xu W, Xu L, Li X, Zhou G, Gu Y, Xu J Injury to peripheral nerves always results in progressive skeletal muscle atrophy and poor functional recovery. Previous studies have demonstrated that transplanting neural stem cells (NSCs) into peripheral nerve can differentiate into neurons and delay muscle atrophy. ]]></description>
			<content:encoded><![CDATA[<p> Microsurgery . 2009 Dec 4; Gu S, Shen Y, Xu W, Xu L, Li X, Zhou G, Gu Y, Xu J Injury to peripheral nerves always results in progressive skeletal muscle atrophy and poor functional recovery. Previous studies have demonstrated that transplanting neural stem cells (NSCs) into peripheral nerve can differentiate into neurons and delay muscle atrophy. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/application-of-fetal-neural-stem-cells-transplantation-in-delaying-denervated-muscle-atrophy-in-rats-with-peripheral-nerve-injury/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Estrogen receptor beta ligands: Recent advances and biomedical applications.</title>
		<link>http://www.betafootprint.com/medical-news/estrogen-receptor-beta-ligands-recent-advances-and-biomedical-applications/</link>
		<comments>http://www.betafootprint.com/medical-news/estrogen-receptor-beta-ligands-recent-advances-and-biomedical-applications/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 09:34:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[biological]]></category>
		<category><![CDATA[biology]]></category>
		<category><![CDATA[description]]></category>
		<category><![CDATA[detailed-review]]></category>
		<category><![CDATA[develop-ligands]]></category>
		<category><![CDATA[important-tools]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[selective]]></category>
		<category><![CDATA[structure]]></category>
		<category><![CDATA[structures]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[study-provides]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/estrogen-receptor-beta-ligands-recent-advances-and-biomedical-applications/</guid>
		<description><![CDATA[ Med Res Rev . 2009 Dec 4; Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA Recent work elucidating the role that the estrogen receptor beta (ERbeta), a member of the nuclear receptor superfamily, plays in regulating various physiological functions has highlighted the potential of this receptor subtype as a therapeutic target for several pathologies. In fact, molecules that are able to selectively activate ERbeta hold promise for the treatment of certain cancers, as well as endometriosis, inflammatory diseases including rheumatoid arthritis, and cardiovascular and CNS conditions. ]]></description>
			<content:encoded><![CDATA[<p> Med Res Rev . 2009 Dec 4; Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA Recent work elucidating the role that the estrogen receptor beta (ERbeta), a member of the nuclear receptor superfamily, plays in regulating various physiological functions has highlighted the potential of this receptor subtype as a therapeutic target for several pathologies. In fact, molecules that are able to selectively activate ERbeta hold promise for the treatment of certain cancers, as well as endometriosis, inflammatory diseases including rheumatoid arthritis, and cardiovascular and CNS conditions. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/estrogen-receptor-beta-ligands-recent-advances-and-biomedical-applications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Exercise Reduces Death Rate In Prostate Cancer Patients</title>
		<link>http://www.betafootprint.com/uncategorized/exercise-reduces-death-rate-in-prostate-cancer-patients/</link>
		<comments>http://www.betafootprint.com/uncategorized/exercise-reduces-death-rate-in-prostate-cancer-patients/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[harvard]]></category>
		<category><![CDATA[harvard-school]]></category>
		<category><![CDATA[mortality-rates]]></category>
		<category><![CDATA[public-health]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[results-suggest]]></category>
		<category><![CDATA[saw-benefits]]></category>
		<category><![CDATA[some-physical]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[very-attainable]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/exercise-reduces-death-rate-in-prostate-cancer-patients/</guid>
		<description><![CDATA[As little as 15 minutes of exercise a day can reduce overall mortality rates in patients with prostate cancer, according to findings presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held here, Dec. 6-9, 2009. ]]></description>
			<content:encoded><![CDATA[<p>As little as 15 minutes of exercise a day can reduce overall mortality rates in patients with prostate cancer, according to findings presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held here, Dec. 6-9, 2009. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/exercise-reduces-death-rate-in-prostate-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Injections Aren&#8217;t Solution for Retained Placenta: Study</title>
		<link>http://www.betafootprint.com/uncategorized/injections-arent-solution-for-retained-placenta-study/</link>
		<comments>http://www.betafootprint.com/uncategorized/injections-arent-solution-for-retained-placenta-study/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 07:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[editorial]]></category>
		<category><![CDATA[editorial-review]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[health-news]]></category>
		<category><![CDATA[injections]]></category>
		<category><![CDATA[retained]]></category>
		<category><![CDATA[retained-placenta]]></category>
		<category><![CDATA[solution]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/injections-arent-solution-for-retained-placenta-study/</guid>
		<description><![CDATA[Title: Injections Aren't Solution for Retained Placenta: Study Category: Health News Created: 12/8/2009 8:10:00 AM Last Editorial Review: 12/8/2009]]></description>
			<content:encoded><![CDATA[<p>Title: Injections Aren&#8217;t Solution for Retained Placenta: Study Category: Health News Created: 12/8/2009 8:10:00 AM Last Editorial Review: 12/8/2009</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/injections-arent-solution-for-retained-placenta-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Malnutrition Costing Australian Hospitals And Patients</title>
		<link>http://www.betafootprint.com/uncategorized/malnutrition-costing-australian-hospitals-and-patients/</link>
		<comments>http://www.betafootprint.com/uncategorized/malnutrition-costing-australian-hospitals-and-patients/#comments</comments>
		<pubDate>Mon, 07 Dec 2009 20:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[australian]]></category>
		<category><![CDATA[dietetics]]></category>
		<category><![CDATA[four-hospital]]></category>
		<category><![CDATA[nutrition]]></category>
		<category><![CDATA[nutrition / diet]]></category>
		<category><![CDATA[poor-patient]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[result]]></category>
		<category><![CDATA[small-number]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[these-patients]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/malnutrition-costing-australian-hospitals-and-patients/</guid>
		<description><![CDATA[New Australian research has revealed one in four hospital patients are malnourished - and many of these patients are not being picked up by hospital staff. According to the study in Nutrition and Dietetics published by Wiley-Blackwell, the result is poor patient outcomes and added financial pressure for hospitals]]></description>
			<content:encoded><![CDATA[<p>New Australian research has revealed one in four hospital patients are malnourished &#8211; and many of these patients are not being picked up by hospital staff. According to the study in Nutrition and Dietetics published by Wiley-Blackwell, the result is poor patient outcomes and added financial pressure for hospitals</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/malnutrition-costing-australian-hospitals-and-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Characteristics associated with early and late melanoma metastases.</title>
		<link>http://www.betafootprint.com/medical-news/characteristics-associated-with-early-and-late-melanoma-metastases-2/</link>
		<comments>http://www.betafootprint.com/medical-news/characteristics-associated-with-early-and-late-melanoma-metastases-2/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 12:54:56 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[analysis]]></category>
		<category><![CDATA[authors]]></category>
		<category><![CDATA[control-patient]]></category>
		<category><![CDATA[extensive-study]]></category>
		<category><![CDATA[late-metastases]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[risk-factors]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/characteristics-associated-with-early-and-late-melanoma-metastases-2/</guid>
		<description><![CDATA[ Cancer . 2009 Nov 13; Brauer JA, Wriston CC, Troxel AB, Elenitsas R, Shin DB, Guerry D, Ming ME BACKGROUND:: Differences in risk factors for metastases at different time intervals after treatment have been described in several malignancies; however, to the authors' knowledge, no extensive study examining this issue in melanoma has been conducted to date. METHODS:: The authors performed a nested case-control study of patients with melanoma who presented with only local disease]]></description>
			<content:encoded><![CDATA[<p> Cancer . 2009 Nov 13; Brauer JA, Wriston CC, Troxel AB, Elenitsas R, Shin DB, Guerry D, Ming ME BACKGROUND:: Differences in risk factors for metastases at different time intervals after treatment have been described in several malignancies; however, to the authors&#8217; knowledge, no extensive study examining this issue in melanoma has been conducted to date. METHODS:: The authors performed a nested case-control study of patients with melanoma who presented with only local disease</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/characteristics-associated-with-early-and-late-melanoma-metastases-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Characteristics associated with early and late melanoma metastases.</title>
		<link>http://www.betafootprint.com/medical-news/characteristics-associated-with-early-and-late-melanoma-metastases/</link>
		<comments>http://www.betafootprint.com/medical-news/characteristics-associated-with-early-and-late-melanoma-metastases/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 12:54:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[analysis]]></category>
		<category><![CDATA[authors]]></category>
		<category><![CDATA[control-patient]]></category>
		<category><![CDATA[extensive-study]]></category>
		<category><![CDATA[late-metastases]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[risk-factors]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/characteristics-associated-with-early-and-late-melanoma-metastases/</guid>
		<description><![CDATA[ Cancer . 2009 Nov 13; Brauer JA, Wriston CC, Troxel AB, Elenitsas R, Shin DB, Guerry D, Ming ME BACKGROUND:: Differences in risk factors for metastases at different time intervals after treatment have been described in several malignancies; however, to the authors' knowledge, no extensive study examining this issue in melanoma has been conducted to date]]></description>
			<content:encoded><![CDATA[<p> Cancer . 2009 Nov 13; Brauer JA, Wriston CC, Troxel AB, Elenitsas R, Shin DB, Guerry D, Ming ME BACKGROUND:: Differences in risk factors for metastases at different time intervals after treatment have been described in several malignancies; however, to the authors&#8217; knowledge, no extensive study examining this issue in melanoma has been conducted to date</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/characteristics-associated-with-early-and-late-melanoma-metastases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind,&#8230;</title>
		<link>http://www.betafootprint.com/medical-news/effect-of-progesterone-on-cervical-shortening-in-women-at-risk-for-preterm-birth-secondary-analysis-from-a-multinational-randomized-double-blind/</link>
		<comments>http://www.betafootprint.com/medical-news/effect-of-progesterone-on-cervical-shortening-in-women-at-risk-for-preterm-birth-secondary-analysis-from-a-multinational-randomized-double-blind/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 12:54:51 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[alters-cervical]]></category>
		<category><![CDATA[cervical-length]]></category>
		<category><![CDATA[difference]]></category>
		<category><![CDATA[obstet-gynecol]]></category>
		<category><![CDATA[placebo]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[preserving-more]]></category>
		<category><![CDATA[preterm-birth]]></category>
		<category><![CDATA[progesterone]]></category>
		<category><![CDATA[secondary]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[subpopulation]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[treatment-group]]></category>
		<category><![CDATA[women-at-high]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/effect-of-progesterone-on-cervical-shortening-in-women-at-risk-for-preterm-birth-secondary-analysis-from-a-multinational-randomized-double-blind/</guid>
		<description><![CDATA[ Ultrasound Obstet Gynecol . ]]></description>
			<content:encoded><![CDATA[<p> Ultrasound Obstet Gynecol . </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/effect-of-progesterone-on-cervical-shortening-in-women-at-risk-for-preterm-birth-secondary-analysis-from-a-multinational-randomized-double-blind/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.</title>
		<link>http://www.betafootprint.com/medical-news/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis-2/</link>
		<comments>http://www.betafootprint.com/medical-news/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis-2/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 12:54:45 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[1547-genotype]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[hadziyannis]]></category>
		<category><![CDATA[lower-relapse]]></category>
		<category><![CDATA[rates-decreased]]></category>
		<category><![CDATA[severe-disease]]></category>
		<category><![CDATA[strongest]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[weeks-enrolled]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis-2/</guid>
		<description><![CDATA[ Hepatology . 2009 Sep 29; Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis/cirrhosis) treated for 16 or 24 weeks enrolled in three randomized international studies were analyzed]]></description>
			<content:encoded><![CDATA[<p> Hepatology . 2009 Sep 29; Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis/cirrhosis) treated for 16 or 24 weeks enrolled in three randomized international studies were analyzed</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.</title>
		<link>http://www.betafootprint.com/medical-news/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis/</link>
		<comments>http://www.betafootprint.com/medical-news/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 12:54:45 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[1547-genotype]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[hadziyannis]]></category>
		<category><![CDATA[lower-relapse]]></category>
		<category><![CDATA[rates-decreased]]></category>
		<category><![CDATA[severe-disease]]></category>
		<category><![CDATA[strongest]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[weeks-enrolled]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis/</guid>
		<description><![CDATA[ Hepatology . 2009 Sep 29; Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40KD)/ribavirin in patients with advanced fibrosis]]></description>
			<content:encoded><![CDATA[<p> Hepatology . 2009 Sep 29; Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, Hadziyannis SJ, Marcellin P The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40KD)/ribavirin in patients with advanced fibrosis</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/efficacy-and-safety-of-peginterferon-alfa-2a-40kd-plus-ribavirin-in-hepatitis-c-patients-with-advanced-fibrosis-and-cirrhosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Some Obese People Perceive Body Size As OK, Dismiss Need To Lose Weight</title>
		<link>http://www.betafootprint.com/uncategorized/some-obese-people-perceive-body-size-as-ok-dismiss-need-to-lose-weight/</link>
		<comments>http://www.betafootprint.com/uncategorized/some-obese-people-perceive-body-size-as-ok-dismiss-need-to-lose-weight/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 11:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[893-people]]></category>
		<category><![CDATA[association]]></category>
		<category><![CDATA[body]]></category>
		<category><![CDATA[body-size]]></category>
		<category><![CDATA[dallas]]></category>
		<category><![CDATA[dallas-heart]]></category>
		<category><![CDATA[lose-weight]]></category>
		<category><![CDATA[obese-people]]></category>
		<category><![CDATA[scientific]]></category>
		<category><![CDATA[size-or-felt]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/some-obese-people-perceive-body-size-as-ok-dismiss-need-to-lose-weight/</guid>
		<description><![CDATA[Some obese people misperceive that their body size is normal and think they don't need to lose weight, according to research presented at the American Heart Association's Scientific Sessions 2009. In the Dallas Heart Study of 5,893 people, researchers found that 8 percent of the 2,056 who were obese said they were satisfied with their body size or felt they could gain weight]]></description>
			<content:encoded><![CDATA[<p>Some obese people misperceive that their body size is normal and think they don&#8217;t need to lose weight, according to research presented at the American Heart Association&#8217;s Scientific Sessions 2009. In the Dallas Heart Study of 5,893 people, researchers found that 8 percent of the 2,056 who were obese said they were satisfied with their body size or felt they could gain weight</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/some-obese-people-perceive-body-size-as-ok-dismiss-need-to-lose-weight/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Winston Laboratories, Inc. Announces Positive Top-line Results Of Phase II Clinical Trial Of Civamide Patch</title>
		<link>http://www.betafootprint.com/uncategorized/winston-laboratories-inc-announces-positive-top-line-results-of-phase-ii-clinical-trial-of-civamide-patch/</link>
		<comments>http://www.betafootprint.com/uncategorized/winston-laboratories-inc-announces-positive-top-line-results-of-phase-ii-clinical-trial-of-civamide-patch/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[civamide]]></category>
		<category><![CDATA[evaluating-the-safety]]></category>
		<category><![CDATA[laboratories]]></category>
		<category><![CDATA[pain / anesthetics]]></category>
		<category><![CDATA[phase]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-treatment]]></category>
		<category><![CDATA[today-announced]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[winston]]></category>
		<category><![CDATA[winston-pharmaceuticals]]></category>
		<category><![CDATA[wphm]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/winston-laboratories-inc-announces-positive-top-line-results-of-phase-ii-clinical-trial-of-civamide-patch/</guid>
		<description><![CDATA[Winston Laboratories, Inc. ]]></description>
			<content:encoded><![CDATA[<p>Winston Laboratories, Inc. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/winston-laboratories-inc-announces-positive-top-line-results-of-phase-ii-clinical-trial-of-civamide-patch/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Family Screening in Patients with Retinal Angiomatosis.</title>
		<link>http://www.betafootprint.com/medical-news/family-screening-in-patients-with-retinal-angiomatosis/</link>
		<comments>http://www.betafootprint.com/medical-news/family-screening-in-patients-with-retinal-angiomatosis/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 20:32:52 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[medical news]]></category>
		<category><![CDATA[affected]]></category>
		<category><![CDATA[necessity]]></category>
		<category><![CDATA[presence]]></category>
		<category><![CDATA[relatives-were]]></category>
		<category><![CDATA[results]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-detection]]></category>
		<category><![CDATA[the-necessity]]></category>
		<category><![CDATA[their-treatment]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[vhl]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/family-screening-in-patients-with-retinal-angiomatosis/</guid>
		<description><![CDATA[ Klin Monbl Augenheilkd . 2009 Nov; 226(11): 939-943 Kreusel KM, Krause L, Graul-Neumann L, Bechrakis NE, Neumann HP, Foerster MH BACKGROUND: The aim of this study was to characterise the results of a screening for von Hippel-Lindau disease (VHL), angiomatosis retinae (AR) and further VHL lesions in at-risk relatives of ophthalmological VHL index patients]]></description>
			<content:encoded><![CDATA[<p> Klin Monbl Augenheilkd . 2009 Nov; 226(11): 939-943 Kreusel KM, Krause L, Graul-Neumann L, Bechrakis NE, Neumann HP, Foerster MH BACKGROUND: The aim of this study was to characterise the results of a screening for von Hippel-Lindau disease (VHL), angiomatosis retinae (AR) and further VHL lesions in at-risk relatives of ophthalmological VHL index patients</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/medical-news/family-screening-in-patients-with-retinal-angiomatosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Uninsured Trauma Patients More Likely to Die: Study</title>
		<link>http://www.betafootprint.com/uncategorized/uninsured-trauma-patients-more-likely-to-die-study/</link>
		<comments>http://www.betafootprint.com/uncategorized/uninsured-trauma-patients-more-likely-to-die-study/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 07:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[editorial]]></category>
		<category><![CDATA[editorial-review]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[health-news]]></category>
		<category><![CDATA[patients]]></category>
		<category><![CDATA[patients-more]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[uninsured]]></category>
		<category><![CDATA[uninsured-trauma]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/uninsured-trauma-patients-more-likely-to-die-study/</guid>
		<description><![CDATA[Title: Uninsured Trauma Patients More Likely to Die: Study Category: Health News Created: 11/17/2009 8:10:00 AM Last Editorial Review: 11/17/2009]]></description>
			<content:encoded><![CDATA[<p>Title: Uninsured Trauma Patients More Likely to Die: Study Category: Health News Created: 11/17/2009 8:10:00 AM Last Editorial Review: 11/17/2009</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/uninsured-trauma-patients-more-likely-to-die-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott Statement On ARBITER 6 &#8211; HALTS Results And Abbott&#8217;s Niaspan (Niacin Extended-Release)</title>
		<link>http://www.betafootprint.com/uncategorized/abbott-statement-on-arbiter-6-halts-results-and-abbotts-niaspan-niacin-extended-release/</link>
		<comments>http://www.betafootprint.com/uncategorized/abbott-statement-on-arbiter-6-halts-results-and-abbotts-niaspan-niacin-extended-release/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 13:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[from-the-investigator]]></category>
		<category><![CDATA[halts]]></category>
		<category><![CDATA[high-cardiovascular]]></category>
		<category><![CDATA[investigator]]></category>
		<category><![CDATA[niacin-extended-release]]></category>
		<category><![CDATA[patients-at-high]]></category>
		<category><![CDATA[risk-had]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[study-showed]]></category>
		<category><![CDATA[the-study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/abbott-statement-on-arbiter-6-halts-results-and-abbotts-niaspan-niacin-extended-release/</guid>
		<description><![CDATA[Results from the investigator-initiated ARBITER 6 - HALTS study showed patients at high cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of therapy with Abbott's Niaspan® (niacin extended-release tablets) plus a statin, the study's primary endpoint. ]]></description>
			<content:encoded><![CDATA[<p>Results from the investigator-initiated ARBITER 6 &#8211; HALTS study showed patients at high cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of therapy with Abbott&#8217;s Niaspan® (niacin extended-release tablets) plus a statin, the study&#8217;s primary endpoint. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/abbott-statement-on-arbiter-6-halts-results-and-abbotts-niaspan-niacin-extended-release/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pot Might Ease PTSD: Study</title>
		<link>http://www.betafootprint.com/uncategorized/pot-might-ease-ptsd-study/</link>
		<comments>http://www.betafootprint.com/uncategorized/pot-might-ease-ptsd-study/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 07:00:00 +0000</pubDate>
		<dc:creator>Master</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[editorial]]></category>
		<category><![CDATA[editorial-review]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[health-news]]></category>
		<category><![CDATA[might-ease]]></category>
		<category><![CDATA[ptsd]]></category>
		<category><![CDATA[study]]></category>

		<guid isPermaLink="false">http://www.the-health-book.com/uncategorized/pot-might-ease-ptsd-study/</guid>
		<description><![CDATA[Title: Pot Might Ease PTSD: Study Category: Health News Created: 11/13/2009 4:10:00 PM Last Editorial Review: 11/16/2009]]></description>
			<content:encoded><![CDATA[<p>Title: Pot Might Ease PTSD: Study Category: Health News Created: 11/13/2009 4:10:00 PM Last Editorial Review: 11/16/2009</p>
]]></content:encoded>
			<wfw:commentRss>http://www.betafootprint.com/uncategorized/pot-might-ease-ptsd-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
